Hindustan Times — News Tracking and Analysis

Hindustan Times is a Youtube. It is based in India. It covers World news. Its media bias rating is lean left. Real Narrative News tracks and rates Hindustan Times for bias and reliability.

Hindustan Times is ranked #183 in World with a score of 7.1 on the Media Scale Index.

Recent headlines from Hindustan Times include: "Who is Deepak Kumar? Indian migrant with California commercial license arrested over $3M theft"; "Who is Dr. Roger Mitchell? All we know about forensic pathologist who performed autopsy on Nolan Wells"; "‘Will bomb bridge, power plants if ships struck in Hormuz’: Trump's big warning to Iran as war escalates"; "AMD to invest up to $5 billion in Anthropic as AI startup buys AMD chips"; "Cetirizine hydrochloride: Why was the allergy medication recalled? Check affected lots, risks and what to do". We track 984 articles from this source.

Latest Articles from Hindustan Times

• Who is Deepak Kumar? Indian migrant with California commercial license arrested over $3M theft — A California truck driver, Deepak Kumar, has been arrested for allegedly transporting 2.857 million in stolen tungsten oxide powder.
• Who is Dr. Roger Mitchell? All we know about forensic pathologist who performed autopsy on Nolan Wells — Nolan Wells' independent autopsy report concludes his cause of death is ‘undetermined’. Here's what we know about Dr. Roger Mitchell who conducted autopsy.
• ‘Will bomb bridge, power plants if ships struck in Hormuz’: Trump's big warning to Iran as war escalates — Trump's warning comes as the US carried out its 11th consecutive night of strikes against Iran as diplomatic efforts to end the war collapse.
• AMD to invest up to $5 billion in Anthropic as AI startup buys AMD chips — AMD will invest up to 5 billion in Anthropic, while the AI startup plans to buy AMD chips starting in 2027 to expand AI computing capacity.
• Cetirizine hydrochloride: Why was the allergy medication recalled? Check affected lots, risks and what to do — Rising Pharma Holdings recalled cetirizine hydrochloride tablets. The FDA advises affected consumers to seek medical advice.